Balloon angioplasty is increasingly being used to carry out various specific tasks during surgeries, such as scoring, cutting, and drug eluting. Manufacturers of angioplasty balloons are focusing on improving patient outcomes by constantly upgrading their existing products. Balloon angioplasty is widely preferred for being minimally-invasive, and can be performed under local anaesthesia, wherein, the patient can be discharged within 24 hours after the surgery, in most cases. Moreover, drug-coated balloon angioplasty, in particular, results in significantly lower post-surgery care, and has been associated with lesser long-term reintervention rates as compared to regular angioplasty.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4318
On the back of these factors, Fact.MR estimates the global angioplasty balloons market to be valued at US$ 2.4 Bn in 2020. However, recent unfavourable changes in the reimbursement scenario are expected to peg market growth in the near future, with a projected CAGR of 3.5% over the forecast period (2020 to 2025).
Angioplasty Balloons Market: Key Takeaways
- Semi-compliant balloons are expected to be the most preferred angioplasty balloons, accounting for over three quarters of the market revenue. This is mainly due to their easy tracking and high resistance to punctures.
- Normal balloons, though having reached saturation, are expected to dominate the market in the foreseeable future, albeit at a slow growth rate.
- The high number of favourable patient outcomes position drug-coated angioplasty balloons on the fastest growth trajectory in the market.
- The high prevalence of cardiovascular diseases, and relatively favourable regulatory and reimbursement scenario, make North America the most preferred destination for angioplasty balloon manufacturers.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4318
Angioplasty Balloons Market – Assessment of the Segmentation
The global angioplasty balloons market is segmented based on the balloon type, material, and geography.
| Balloon Type |
- Normal
- Drug-coated
- Cutting
- Scoring
|
| Material |
- Non-compliant
- Semi-compliant
|
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4318
Analysts at Fact.MR opine that, Asia Pacific is emerging as a rapidly-growing regional market, due to the development of healthcare infrastructure and increase in medical expenditure in the region. This would be particularly significant during the forecast period, as the incidence of CVD is set to grow, alongside increased healthcare spending in APAC. These factors are opening up a plethora of opportunities for manufacturers in the APAC angioplasty balloons market.
Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2018/11/19/1653599/0/en/Global-Dental-Restorative-Supplies-Market-Indirect-Restoration-Segment-to-Deliver-Greater-Demand-in-Comparison-to-Direct-Restoration-Segment-Reports-Fact-MR.html
Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape
Ventricular Restoration Systems Market Forecast, Trend Analysis, & Competition Tracking – Global Review 2020 to 2030- https://www.factmr.com/report/5288/ventricular-restoration-systems-market
Inhalational Anaesthesia Drugs Market Forecast, Trend Analysis, & Competition Tracking – Global Review 2020 to 2030- https://www.factmr.com/report/5290/inhalational-anaesthesia-drugs-market
Ambulatory heart Monitor Market Forecast Trend Analysis & Competition Tracking – Global Review 2020 to 2030- https://www.factmr.com/report/5195/ambulatory-heart-monitor-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
